NASDAQ:ONEM - 1Life Healthcare Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $47.81
  • Forecasted Upside: 39.44 %
  • Number of Analysts: 16
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 14 Buy Ratings
  • 0 Strong Buy Ratings
$34.29
▲ +0.03 (0.09%)
1 month | 3 months | 12 months
Get New 1Life Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ONEM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ONEM

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$47.81
▲ +39.44% Upside Potential
This price target is based on 16 analysts offering 12 month price targets for 1Life Healthcare in the last 3 months. The average price target is $47.81, with a high forecast of $63.00 and a low forecast of $28.00. The average price target represents a 39.44% upside from the last price of $34.29.

Buy

The current consensus among 16 investment analysts is to buy stock in 1Life Healthcare.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/22/2019
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/21/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/19/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/17/2020
  • 0 strong buy ratings
  • 11 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/16/2020
  • 0 strong buy ratings
  • 10 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/16/2021
  • 0 strong buy ratings
  • 12 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/15/2021
  • 0 strong buy ratings
  • 14 buy ratings
  • 2 hold ratings
  • 0 sell ratings
6/14/2021

Latest Recommendations

  • 0 strong buy ratings
  • 14 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/9/2021Deutsche Bank AktiengesellschaftLower Price TargetBuy$50.00 ➝ $39.00Medium
i
Rating by George Hill at Deutsche Bank Aktiengesellschaft
5/27/2021Robert W. BairdInitiated CoverageOutperform$43.00High
i
5/21/2021KeyCorpInitiated CoverageOverweight$41.00Medium
i
5/17/2021Credit Suisse GroupLower Price TargetOutperform$56.00 ➝ $50.00Low
i
5/13/2021TruistLower Price TargetBuy ➝ Buy$56.00 ➝ $48.00Low
i
Rating by Sandy Draper at Truist
5/13/2021Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellLower Price TargetBuy ➝ Buy$61.00 ➝ $55.00High
i
5/13/2021CitigroupLower Price TargetBuy ➝ Buy$61.00 ➝ $55.00High
i
Rating by Daniel Grosslight at Citigroup Inc.
5/13/2021Canaccord GenuityLower Price TargetBuy$64.00 ➝ $56.00High
i
5/3/2021Jefferies Financial GroupInitiated CoverageBuy$63.00Medium
i
3/15/2021Evercore ISIInitiated CoverageOutperform$48.00Medium
i
3/1/2021Credit Suisse GroupBoost Price TargetOutperform$40.00 ➝ $56.00N/A
i
3/1/2021Morgan StanleyBoost Price TargetOverweight$44.00 ➝ $50.00N/A
i
2/26/2021TruistBoost Price Target$40.00 ➝ $56.00Low
i
2/26/2021SVB LeerinkLower Price TargetOutperform$55.00 ➝ $53.00Medium
i
Rating by S. Davis at SVB Leerink LLC
2/26/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$42.00 ➝ $53.00Medium
i
2/4/2021CitigroupBoost Price Target$42.00 ➝ $62.00Low
i
1/29/2021SVB LeerinkUpgradeMarket Perform ➝ Outperform$38.00 ➝ $55.00Low
i
Rating by S. Davis at SVB Leerink LLC
1/8/2021Piper SandlerBoost Price TargetOverweight$44.00 ➝ $51.00Low
i
1/7/2021Canaccord GenuityBoost Price TargetFocus Stock ➝ Buy$46.00 ➝ $50.00Low
i
1/6/2021BTIG ResearchInitiated CoverageNeutralN/A
i
12/16/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$38.00 ➝ $42.00High
i
12/16/2020Canaccord GenuityBoost Price TargetBuy$41.00 ➝ $46.00High
i
Rating by Richard Close at Canaccord Genuity
11/11/2020Smith Barney CitigroupBoost Price Target$38.00 ➝ $42.00Low
i
11/11/2020Canaccord GenuityBoost Price TargetBuy$39.00 ➝ $41.00Low
i
Rating by Richard Close at Canaccord Genuity
11/11/2020JPMorgan Chase & Co.Reiterated RatingOverweight$40.00 ➝ $43.00High
i
11/11/2020Credit Suisse GroupBoost Price TargetOutperform$37.00 ➝ $40.00High
i
11/11/2020Piper SandlerBoost Price TargetOverweight$43.00 ➝ $44.00Medium
i
11/11/2020SVB LeerinkBoost Price TargetMarket Perform$36.00 ➝ $38.00High
i
Rating by D. Ha at SVB Leerink LLC
11/11/2020Morgan StanleyBoost Price TargetOverweight$35.00 ➝ $41.00High
i
10/30/2020Credit Suisse GroupInitiated CoverageOutperform$37.00High
i
10/14/2020Deutsche Bank AktiengesellschaftInitiated CoverageBuy$37.00High
i
8/14/2020TruistBoost Price Target$30.00 ➝ $36.00Medium
i
8/13/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$23.00 ➝ $28.00Medium
i
Rating by Jamie Stockton at Wells Fargo & Company
7/17/2020Piper SandlerBoost Price TargetOverweight$40.00 ➝ $43.00Medium
i
Rating by Sean Wieland at Piper Sandler
7/8/2020CitigroupBoost Price TargetPositive ➝ Neutral$20.00 ➝ $38.00Low
i
Rating by Ralph Giacobbe at Citigroup Inc.
7/1/2020SVB LeerinkInitiated CoverageMarket Perform$36.00Medium
i
Rating by D. Ha at SVB Leerink LLC
6/30/2020Piper SandlerBoost Price TargetOverweight$29.00 ➝ $40.00High
i
Rating by Sean Wieland at Piper Sandler
6/19/2020Canaccord GenuityInitiated CoverageBuy$39.00High
i
5/18/2020Morgan StanleyBoost Price TargetOverweight$21.00 ➝ $35.00Medium
i
Rating by Ricky Goldwasser at Morgan Stanley
5/14/2020SunTrust BanksBoost Price TargetBuy$26.00 ➝ $30.00Medium
i
Rating by Sandy Draper at SunTrust Banks, Inc.
5/14/2020Piper SandlerReiterated RatingOverweight$27.00 ➝ $29.00High
i
Rating by Sean Wieland at Piper Sandler
5/14/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$18.00 ➝ $23.00High
i
Rating by Jamie Stockton at Wells Fargo & Company
4/1/2020CitigroupLower Price TargetNeutral$25.00 ➝ $20.00High
i
Rating by Ralph Giacobbe at Citigroup Inc.
3/19/2020Morgan StanleyLower Price TargetOverweight$27.00 ➝ $21.00High
i
Rating by Ricky Goldwasser at Morgan Stanley
2/25/2020Morgan StanleyInitiated CoverageOverweight$27.00High
i
2/25/2020Wells Fargo & CompanyInitiated CoverageEqual Weight$24.00High
i
2/25/2020Robert W. BairdInitiated CoverageNeutral$24.00High
i
2/25/2020JPMorgan Chase & Co.Initiated CoverageOverweight$28.00High
i
2/25/2020SunTrust BanksInitiated CoverageBuy$30.00High
i
2/25/2020CitigroupInitiated CoverageNeutral$25.00High
i
2/25/2020William BlairInitiated CoverageOutperformHigh
i
Rating by R. Daniels at William Blair
2/25/2020Piper SandlerInitiated CoverageOverweight$29.00High
i
(Data available from 6/14/2016 forward)
1Life Healthcare logo
1Life Healthcare, Inc. operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as employer sponsorship. Its membership model includes seamless access to digital health services paired with inviting in-office care routinely covered under health insurance programs. The company also offers administrative and managerial services pursuant to contracts with physician-owned professional corporations or One Medical Entities. As of December 31, 2020, it had approximately 549,000 members in 13 markets in the United States; and 8,000 enterprise clients. The company was incorporated in 2002 and is headquartered in San Francisco, California.
Read More

Today's Range

Now: $34.29
$33.94
$34.74

50 Day Range

MA: $38.52
$32.76
$44.64

52 Week Range

Now: $34.29
$25.40
$59.82

Volume

893,123 shs

Average Volume

1,341,824 shs

Market Capitalization

$4.71 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.3

Frequently Asked Questions

What sell-side analysts currently cover shares of 1Life Healthcare?

The following Wall Street sell-side analysts have issued research reports on 1Life Healthcare in the last year: BTIG Research, Canaccord Genuity, Citigroup Inc., Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Evercore ISI, Jefferies Financial Group Inc., JPMorgan Chase & Co., KeyCorp, Morgan Stanley, Piper Sandler, Robert W. Baird, Smith Barney Citigroup, SVB Leerink LLC, Truist, Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for ONEM.

What is the current price target for 1Life Healthcare?

16 Wall Street analysts have set twelve-month price targets for 1Life Healthcare in the last year. Their average twelve-month price target is $47.81, suggesting a possible upside of 39.4%. Jefferies Financial Group Inc. has the highest price target set, predicting ONEM will reach $63.00 in the next twelve months. Wells Fargo & Company has the lowest price target set, forecasting a price of $28.00 for 1Life Healthcare in the next year.
View the latest price targets for ONEM.

What is the current consensus analyst rating for 1Life Healthcare?

1Life Healthcare currently has 2 hold ratings and 14 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ONEM will outperform the market and that investors should add to their positions of 1Life Healthcare.
View the latest ratings for ONEM.

What other companies compete with 1Life Healthcare?

Other companies that are similar to 1Life Healthcare include Hims & Hers Health, Cano Health, Jaws Acquisition, LifeMD, Concord Medical Services and WellQuest Medical & Wellness.

How do I contact 1Life Healthcare's investor relations team?

1Life Healthcare's physical mailing address is One Embarcadero Center Suite 1900, San Francisco CA, 94111. The company's listed phone number is 415-814-0927 and its investor relations email address is [email protected] The official website for 1Life Healthcare is www.onemedical.com.